Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

134.88
Delayed Data
As of Jul 29
 -0.01 / -0.01%
Today’s Change
71.63
Today|||52-Week Range
138.94
+24.41%
Year-to-Date
Ligand Pharmaceuticals (LGND) Jumps: Stock Rises 5.5%
Jul 21 / Zacks.com - Paid Partner Content
4 Rock-Solid, Cheap Biotech Stocks
Jul 16 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks for Conservative Investors
Jul 17 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close134.89
Today’s open134.55
Day’s range132.69 - 136.31
Volume513,815
Average volume (3 months)388,471
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+2,064.46%
Earnings growth (this year)+1.78%
Earnings growth (next 5 years)+53.87%
Revenue growth (last year)+11.43%
P/E ratio10.9
Price/Sales32.00
Price/Book8.84

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co+0.22+0.57%
HZNPHorizon Pharma PLC-0.33-1.68%
RAREUltragenyx Pharmaceu...+2.27+3.72%
CBPOChina Biologic Produ...-2.22-1.83%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.40
Annual revenue (last year)$71.9M
Annual profit (last year)$257.3M
Net profit margin357.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers

Search for Jobs